Alphadyne Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.72M Sell
17,100
-2,800
-14% -$621K 0.06% 351
2025
Q4
$4.55M Buy
19,900
+11,200
+129% +$2.55M 0.11% 156
2025
Q3
$2.01M Buy
+8,700
New +$1.77M 0.16% 143

Other funds holding ABBV

Alphadyne Asset Management's ABBV Position: Q1 2026 in Review

Alphadyne Asset Management opened a new position in AbbVie (ABBV) in Q1 2026: 3,940 shares worth $857K. The stake represents 0.01% of the portfolio and ranks #599 among its holdings. This is a return to the name: Alphadyne Asset Management previously reported a position in ABBV as recently as Q3 2023.

Alphadyne Asset Management first reported a position in ABBV in Q2 2023 and has held it in 3 quarters since. The position peaked at $1.56M in Q3 2023. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Alphadyne Asset Management held 3,940 shares of AbbVie worth $857K as of Q1 2026.
  • AbbVie was a new Alphadyne Asset Management position in Q1 2026.
  • AbbVie made up 0.01% of Alphadyne Asset Management's portfolio in Q1 2026, its #599 holding.
  • Alphadyne Asset Management first reported a position in AbbVie in Q2 2023 and has held it in 3 quarters since.
  • Alphadyne Asset Management's AbbVie position peaked at $1.56M in Q3 2023.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Alphadyne Asset Management's 13F filing for Q1 2026, filed 15 May 2026.